{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:01Z","timestamp":1740135481231,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sk\u00e5ne University Hospital, Sweden"},{"name":"Westerstr\u00f6ms stiftelse"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1021-7","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:05:33Z","timestamp":1551164733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8966-2112","authenticated-orcid":false,"given":"Karolina","family":"Berntorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha","family":"Koul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahab","family":"Nozohoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Harnek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Bjursten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"G\u00f6tberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"issue":"19","key":"1021_CR1","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.jacc.2014.02.556","volume":"63","author":"JJ Popma","year":"2014","unstructured":"Popma JJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63(19):1972\u201381.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1021_CR2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMc1408396","volume":"371","author":"DH Adams","year":"2014","unstructured":"Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;371(10):967\u20138.","journal-title":"N Engl J Med"},{"issue":"14","key":"1021_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","volume":"376","author":"MJ Reardon","year":"2017","unstructured":"Reardon MJ, et al. Surgical or Transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321\u201331.","journal-title":"N Engl J Med"},{"issue":"23","key":"1021_CR4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith CR, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187\u201398.","journal-title":"N Engl J Med"},{"issue":"17","key":"1021_CR5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon MB, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597\u2013607.","journal-title":"N Engl J Med"},{"issue":"17","key":"1021_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon MB, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609\u201320.","journal-title":"N Engl J Med"},{"issue":"11","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.4244\/EIJV9I11A216","volume":"9","author":"IT Meredith","year":"2014","unstructured":"Meredith IT, et al. Transfemoral aortic valve replacement with the repositionable Lotus valve system in high surgical risk patients: the REPRISE I study. EuroIntervention. 2014;9(11):1264\u201370.","journal-title":"EuroIntervention"},{"issue":"4","key":"1021_CR8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jcin.2015.10.024","volume":"9","author":"IT Meredith","year":"2016","unstructured":"Meredith IT, et al. 1-year outcomes with the fully repositionable and retrievable Lotus Transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: Results of the REPRISE II Study. JACC Cardiovasc Interv. 2016;9(4):376\u201384.","journal-title":"JACC Cardiovasc Interv"},{"key":"1021_CR9","doi-asserted-by":"crossref","unstructured":"Gotzmann M., et al., Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J, 2011. 162(2): p. 238\u2013245 e1.","DOI":"10.1016\/j.ahj.2011.05.011"},{"issue":"11","key":"1021_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/hrt.2010.217158","volume":"97","author":"M Abdel-Wahab","year":"2011","unstructured":"Abdel-Wahab M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97(11):899\u2013906.","journal-title":"Heart"},{"issue":"6","key":"1021_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.4244\/EIJV12I6A124","volume":"12","author":"J Wohrle","year":"2016","unstructured":"Wohrle J, et al. Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-Centre experience. EuroIntervention. 2016;12(6):760\u20137.","journal-title":"EuroIntervention"},{"issue":"4","key":"1021_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1540-8167.2011.02211.x","volume":"23","author":"D Erkapic","year":"2012","unstructured":"Erkapic D, et al. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23(4):391\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"1021_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jacc.2014.04.033","volume":"64","author":"GC Siontis","year":"2014","unstructured":"Siontis GC, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"1021_CR14","doi-asserted-by":"crossref","unstructured":"Falk V, et al. Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND study. Eur Heart J. 2017.","DOI":"10.1093\/eurheartj\/ehx297"},{"issue":"1","key":"1021_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jtcvs.2012.09.002","volume":"145","author":"AP Kappetein","year":"2013","unstructured":"Kappetein AP, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145(1):6\u201323.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"29","key":"1021_CR16","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"M Brignole","year":"2013","unstructured":"Brignole M, et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC) Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281\u2013329.","journal-title":"Eur Heart J"},{"issue":"6","key":"1021_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2012.03.054","volume":"60","author":"L Buellesfeld","year":"2012","unstructured":"Buellesfeld L, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60(6):493\u2013501.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1021_CR18","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/CIRCULATIONAHA.113.005479","volume":"129","author":"M Urena","year":"2014","unstructured":"Urena M, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129(11):1233\u201343.","journal-title":"Circulation"},{"issue":"1","key":"1021_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12872-016-0466-1","volume":"17","author":"H Bjursten","year":"2017","unstructured":"Bjursten H, et al. The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR. BMC Cardiovasc Disord. 2017;17(1):25.","journal-title":"BMC Cardiovasc Disord"},{"key":"1021_CR20","doi-asserted-by":"crossref","unstructured":"Seeger J, et al. Outcome with the repositionable and retrievable Boston Scientific Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve in patients undergoing Transfemoral aortic valve replacement. Circ Cardiovasc Interv. 2017;10(6).","DOI":"10.1161\/CIRCINTERVENTIONS.116.004670"},{"issue":"7","key":"1021_CR21","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jcin.2015.03.014","volume":"8","author":"RP Gooley","year":"2015","unstructured":"Gooley RP, et al. Comparison of self-expanding and mechanically expanded Transcatheter aortic valve prostheses. JACC Cardiovasc Interv. 2015;8(7):962\u201371.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"1021_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5603\/CJ.a2017.0024","volume":"24","author":"F Krackhardt","year":"2017","unstructured":"Krackhardt F, et al. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol. Cardiol J. 2017;24(3):250\u20138.","journal-title":"Cardiol J"},{"key":"1021_CR23","unstructured":"Tomas Jernberg, D.H., 182 88 Stockholm, SWEDEHEART Annual Report 2017: Percutaneous Valve Registry. 2017: \n                    http:\/\/www.ucr.uu.se\/swedeheart\/\n                    \n                  . p. 204\u2013217."},{"issue":"15","key":"1021_CR24","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jacc.2013.01.047","volume":"61","author":"G Athappan","year":"2013","unstructured":"Athappan G, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/eurheartj\/ehu384","volume":"36","author":"S Kodali","year":"2015","unstructured":"Kodali S, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36(7):449\u201356.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1021-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1021-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1021-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T19:16:18Z","timestamp":1582658178000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1021-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1021-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No specific consent for participation in the registry was needed since the data collected was identical to already available data in SWEDEHEART, which is a national quality registry and does not require consent. The data from the SWEDEHEART and the pacemaker registry is not publically available and therefore required ethics approval which was approved by Lund University ethics committee (LU2009\/87), Lund, Sweden. The study as a whole was also approved by Lund University ethics committee (LU2009\/87), Lund, Sweden, including administrative permission for obtaining and collecting data as well as medical records.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HB, MG, JH has received consulting fees from Boston Scientific corporation to serve as proctors for the Lotus Valve.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"44"}}